TOREMIFENE for Breast cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 114 adverse event reports in the FDA FAERS database where TOREMIFENE was used for Breast cancer.
Most Reported Side Effects for TOREMIFENE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Fatigue | 19 | 7.8% | 0 | 7 |
| Drug ineffective | 17 | 6.9% | 3 | 3 |
| General physical health deterioration | 14 | 5.7% | 1 | 13 |
| Atrial fibrillation | 13 | 5.3% | 0 | 12 |
| Nausea | 12 | 4.9% | 0 | 3 |
| Endometrial hyperplasia | 10 | 4.1% | 0 | 3 |
| Hepatic function abnormal | 10 | 4.1% | 0 | 4 |
| Oedema peripheral | 10 | 4.1% | 0 | 8 |
| Drug-induced liver injury | 9 | 3.7% | 0 | 3 |
| Endometrial thickening | 9 | 3.7% | 0 | 4 |
| Myelosuppression | 9 | 3.7% | 0 | 6 |
| Pyrexia | 9 | 3.7% | 0 | 8 |
| Asthenia | 8 | 3.3% | 0 | 4 |
| Pain | 8 | 3.3% | 0 | 5 |
| Product use issue | 8 | 3.3% | 1 | 2 |
Other Indications for TOREMIFENE
Product used for unknown indication (37)
Invasive ductal breast carcinoma (17)
Breast cancer metastatic (15)
Breast cancer recurrent (11)
Desmoid tumour (6)
Other Drugs Used for Breast cancer
TRASTUZUMAB (15,522)
PALBOCICLIB (13,075)
DOCETAXEL (11,735)
PACLITAXEL (10,215)
LETROZOLE (9,332)
CYCLOPHOSPHAMIDE (8,826)
PERTUZUMAB (7,532)
RIBOCICLIB (6,953)
CAPECITABINE (5,767)
EPIRUBICIN (5,444)